Audiological monitoring of patients undergoing multidrug resistant tuberculosis treatment at Jigme Dorji Wangchuk National Referral Hospital and Gidakom Hospital, Bhutan

BACKGROUND: Hearing impairment due to ototoxicity is one common cause adding to global burden of disability. Amikacin and kanamycin are two common Aminoglycosides used to treat multidrug resistant tuberculosis which results in ototoxicity. The mean prevalence rate of multidrug resistant tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangchuk, Pelden, Ram Adhikari, Tika, Nima, Gaki, Dendup, Phuntsho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056406/
https://www.ncbi.nlm.nih.gov/pubmed/33898763
http://dx.doi.org/10.1016/j.jctube.2021.100229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056406/
https://www.ncbi.nlm.nih.gov/pubmed/33898763
http://dx.doi.org/10.1016/j.jctube.2021.100229

Ejemplares similares